Applied DNA Sciences (APDN) Reports In-Line Q3 EPS, beats revenue
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Depreciation and amortization: 148.53K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Depreciation and amortization: 148.53K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.24), in-line with the analyst estimate of ($0.24). Revenue for the quarter came in at $2.92 million versus the consensus estimate of $2.56 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Robinhood plans $2B convertible notes offering due 2029
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
